Delivery Order SPE2DB22D9239-SPE2DB24FDE54
Award Date 11/27/23
Potential Completion Date 12/18/23
Potential Value $73K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency to provide forty-five hundred sixty-three thousand one hundred forty vials of XENPOZYME 20 MG. The delivery order was awarded on December 6, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical products to the Defense Logistics Agency with a potential value of up to five million dollars through December 2025. Under this particular...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency. This order is being issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide 20 mg vials of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $87,418.08 by the Defense Logistics Agency on July 30, 2025, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XENPOZYME 20 mg vials. The $109,272.60 contract has a completion date of March 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic drugs to government agencies, particularly the Department of Veterans Affairs and Department of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, valued at $87,418.08, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 6, 2024. DMS Pharmaceutical Group is a key supplier for the DLA, holding a $499,999,999 Indefinite Delivery Contract to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $72,848.40 and a completion date of February 2, 2024. The order is for the pharmaceutical product XENPOZYME 20 MG VIALS. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceuticals and medical supplies to the federal government, particularly the Department...
- The Defense Logistics Agency awarded a $253,772.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Xenpozyme 20 mg vials, with an ultimate completion date of October 20, 2025. This delivery order, issued on September 28, 2025, carries no set-aside designation and represents work to be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois and registered in the System for Award Management...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on June 18, 2025, by the Defense Logistics Agency (DLA) for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, valued at $87,418.08, is due for completion by July 11, 2025, and represents the supply of a specialized pharmaceutical product to support Department of Defense healthcare operations. The award was issued without a...